Inhibikase Therapeutics, Inc 10-K for FY2024
Inhibikase Therapeutics, Inc. (IKT)
10-K
2025-03-27
For: 2024-12-31
View Original
Added on
April 07, 2026
About this 10-K
Inhibikase Therapeutics, Inc filed this 10-K on March 27, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $260.5K a year earlier
- Net loss
- $27.52M
- compared with a net loss of $19.03M a year earlier
- Diluted EPS
- -$1.16
- compared with -$3.16 a year earlier